Painless gastrointestinal endoscopy
Conditions
Interventions
experimental group:Remimazolam Tosylate 5 mg intravenously
control group:Propofol 2.5 mg/kg intravenously
Sponsors
Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Subjects of ASA grade I-II; 2. Subjects aged 18-60 years, regardless of gender, 18 kg / m2 < BMI < 30 kg / m2; 3. Subjects with normal liver, kidney and cardiopulmonary function; 4. The patients living at high altitude for more than three months are those who live at an altitude of more than 3000 meters; 5. Subjects whose examination time is less than 30 min; 6. Subjects who participated in this study voluntarily.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of their own diseases, drug abuse and alcohol addiction; 2. Patients with severe liver and kidney dysfunction and electrolyte disorder; 3. Patients who need complex endoscopic diagnosis and treatment techniques (such as cholangiopancreatography, endoscopic ultrasonography, endoscopic mucosal resection, endoscopic submucosal dissection, and oral endoscopic myotomy); 4. Patients with sleep apnea syndrome; 5. Patients allergic to benzodiazepines and opioids; 6. Patients who can't cooperate to complete the experiment due to various reasons; we need to exclude this study and add new patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Huxi pínlu 4/5000 breath rate;blood pressure;Heart rate;Blood oxygen saturation; | — |
Countries
China
Contacts
Public ContactXia Zongjing
Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region
Outcome results
None listed